← Open Payments lookup

ROBERT WILLETT: Open Payments

NPI 1720754096 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,753 in 192 payments from 11 companies in 2025. Trend: 2023 $2,542 · 2024 $2,402 · 2025 $2,753

Food & beverage: $2,647Education: $106
CompanyPaymentsAmount
Alkermes, Inc.18$428
Teva Pharmaceuticals USA, Inc.23$394
Vanda Pharmaceuticals Inc.16$382
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$352
ABBVIE INC.38$331
E.R. Squibb & Sons, L.L.C.43$318
Otsuka America Pharmaceutical, Inc.16$188
Neurocrine BioSciences, Inc.8$152
Lundbeck LLC7$111
Janssen Pharmaceuticals, Inc3$62

Products named: FANAPT, CAPLYTA, VRAYLAR, COBENFY, ARISTADA, AUSTEDO XR, REXULTI, INGREZZA.

Industry payments across AL — which companies pay providers there.